MacroGenics Inc
General ticker "MGNX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $212.2M
MacroGenics Inc does not follow the US Stock Market performance with the rate: -32.3%.
Estimated limits based on current volatility of 2.9%: low 3.11$, high 3.30$
Factors to consider:
- Current price 50.3% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.50$, 13.90$]
- 2024-12-30 to 2025-12-30 estimated range: [5.96$, 12.89$]
Financial Metrics affecting the MGNX estimates:
- Negative: Non-GAAP EPS, $ of -2.24 <= 0.10
- Negative: Operating profit margin, % of -74.12 <= 1.03
- Negative: Operating cash flow per share per price, % of -12.54 <= 2.35
- Positive: -3.48 < Investing cash flow per share, $ of -1.29
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Inventory ratio change, % of 5.12 > 1.08
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term MGNX quotes
Long-term MGNX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $77.45MM | $151.94MM | $58.75MM |
| Operating Expenses | $280.24MM | $273.36MM | $226.99MM |
| Operating Income | $-202.79MM | $-121.42MM | $-168.24MM |
| Non-Operating Income | $0.68MM | $1.66MM | $159.19MM |
| Interest Expense | $0.00MM | $0.26MM | $1.43MM |
| R&D Expense | $214.58MM | $207.03MM | $166.58MM |
| Income(Loss) | $-202.12MM | $-119.76MM | $-9.06MM |
| Profit(Loss) | $-202.12MM | $-119.76MM | $-9.06MM |
| Stockholders Equity | $239.62MM | $142.01MM | $152.61MM |
| Inventory | $4.39MM | $1.45MM | $1.22MM |
| Assets | $335.25MM | $280.47MM | $298.42MM |
| Operating Cash Flow | $-143.83MM | $-86.96MM | $-78.20MM |
| Capital expenditure | $6.20MM | $3.62MM | $1.76MM |
| Investing Cash Flow | $-36.61MM | $70.72MM | $-80.08MM |
| Financing Cash Flow | $122.78MM | $1.66MM | $150.36MM |
| Earnings Per Share* | $-3.18 | $-1.95 | $-0.15 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.